Editorial: prolonged remission from hepatic encephalopathy with rifaximin
Aliment Pharmacol Ther
.
2015 Jan;41(2):228.
doi: 10.1111/apt.13025.
Authors
J G Orr
1
,
M Hudson
Affiliation
1
Liver Unit, Freeman Hospital, Newcastle upon Tyne, UK; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
PMID:
25511766
DOI:
10.1111/apt.13025
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Infective Agents / therapeutic use*
Female
Hepatic Encephalopathy / drug therapy*
Humans
Liver Cirrhosis / drug therapy*
Male
Rifamycins / therapeutic use*
Substances
Anti-Infective Agents
Rifamycins